Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases

International Journal of Pharmaceutics

Volumn 422, Issue 1-2, 2012, Pages 229-237

  Cosco, D ^a   Paolino, D ^a,b   Cilurzo, F ^a   Casale, F ^a   Fresta, M ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UOC Farmacia Ospedaliera   (Italy)

Author keywords

Breast cancer cells; Gemcitabine; Liposomes; Multidrug carrier; Tamoxifen

Indexed keywords

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOCHOLINE MONOHYDRATE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DIOLEOYL TRIMETHYLAMMONIUM PROPANE; DIPALMITOYLPHOSPHATIDYLCHOLINE; GEMCITABINE; LIPOSOME; N(CARBONYL METHOXYPOLYETHYLENE GLYCOL 2000) 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; PHOSPHOETHANOLAMINE; TAMOXIFEN; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL STRAIN T47D; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RELEASE; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID COMPOSITION; LIPOSOMAL DELIVERY; MEMBRANE FLUIDITY; PARTICLE SIZE; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; SURFACE CHARGE; ZETA POTENTIAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; COLLOIDS; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; KINETICS; LIPIDS; LIPOSOMES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS; POLYETHYLENE GLYCOLS; QUATERNARY AMMONIUM COMPOUNDS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SOLUBILITY; TAMOXIFEN; TECHNOLOGY, PHARMACEUTICAL;

EID: 84655163284     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.10.056     Document Type: Article

References (28)

1. M. Airoldi, L. Cattel, P. Milla, F. Pedani, M. Garzaro, and F. Dosio Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions Anticancer Res. 28 2008 2519 2527
2. A. Bhatia, R. Kumar, and O.P. Katare Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation J. Pharm. Pharm. Sci. 7 2004 252 259 (Pubitemid 41528899)
3. H. Brauch, and V.C. Jordan Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the personalized approach? Eur. J. Cancer 45 2009 2274 2283
4. M.G. Calvagno, D. Cosco, C. Celia, D. Paolino, D. Russo, and M. Fresta Liposomal multidrug carriers encapsulating gemcitabine and paclitaxel for the treatment of multi-drug resistant tumors 33rd Annual Meeting & Exposition of the Controlled Release Society Vienna, Austria, 22-26 July 2006 2006 678
5. M.G. Calvagno, C. Celia, D. Paolino, D. Cosco, M. Iannone, F. Castelli, P. Doldo, and M. Fresta Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes Curr. Drug Deliv. 4 2007 89 101 (Pubitemid 46066418)
6. M. Celano, M.G. Calvagno, S. Bulotta, D. Paolino, F. Arturi, D. Rotiroti, S. Filetti, M. Fresta, and D. Russo Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells BMC Cancer 4 2004 63 70
7. M. Celano, S. Schenone, D. Cosco, M. Navarra, E. Puxeddu, L. Racanicchi, C. Brullo, E. Varano, S. Alcaro, E. Ferretti, G. Botta, S. Filetti, M. Fresta, M. Botta, and D. Russo Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo Endocr. Relat. Cancer 15 2008 499 510 (Pubitemid 351880838)
8. C. Celia, M.G. Calvagno, D. Paolino, S. Bulotta, C.A. Ventura, D. Russo, and M. Fresta Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes J. Nanosci. Nanotechnol. 8 2008 2102 2113
9. R. Colomer What is the best schedule for administration of gemcitabine-taxane? Cancer Treat. Rev. 31 2005 S23 S28
10. D. Cosco, A. Bulotta, M. Ventura, C. Celia, T. Calimeri, G. Perri, D. Paolino, N. Costa, P. Neri, P. Tagliaferri, P. Tassone, and M. Fresta In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer Cancer Chemother. Pharmacol. 64 2009 1009 1020
11. D. Cosco, D. Paolino, R. Muzzalupo, C. Celia, R. Citraro, D. Caponio, N. Picci, and M. Fresta Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil Biomed. Microdevices 11 2009 1115 1125
12. D. Cosco, D. Paolino, J. Maiuolo, D. Russo, and M. Fresta Liposomes as multicompartimental carriers for the multidrug delivery in anticancer chemotherapy Drug Deliv. Transl. Res. 1 2011 66 75
13. A.A. Gabizon, H. Shmeeda, and S. Zalipsky Pros and cons of the liposome platform in cancer drug targeting J. Liposome Res. 16 2006 175 183 (Pubitemid 44358991)
14. R. Kayyali, C. Marriott, and H. Wiseman Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells? FEBS Lett. 344 1994 221 224
15. C. Lonez, M. Vandenbranden, and J.M. Ruysschaert Cationic liposomal lipids: from gene carriers to cell signaling Prog. Lipid Res. 47 2008 340 347
16. A. Nagayasu, K. Uchiyama, and H. Kiwada The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs Adv. Drug Deliv. Rev. 40 1999 75 87 (Pubitemid 29486605)
17. D. Paolino, D. Cosco, L. Racanicchi, E. Trapasso, C. Celia, M. Iannone, E. Puxeddu, G. Costante, S. Filetti, D. Russo, and M. Fresta Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: biodistribution, pharmacokinetic features and in vivo antitumor activity J. Control Release 144 2010 144 150
18. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, and F.J. Martin Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U. S. A. 88 1991 11460 11464 (Pubitemid 21916061)
19. G. Pasut, and F.M. Veronese PEGylation for improving the effectiveness of therapeutic biomolecules Drugs Today (Barc.) 45 2009 687 695
20. N.J. Robert, C.L. Vogel, I.C. Henderson, J.A. Sparano, M.R. Moore, P. Silverman, B.A. Overmoyer, C.L. Shapiro, J.W. Park, G.T. Colbern, E.P. Winer, and A.A. Gabizon The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer Semin. Oncol. 31 2004 106 146 (Pubitemid 40023244)
21. N. Silvestris, S. Cinieri, I. La Torre, G. Pezzella, G. Numico, L. Orlando, and V. Lorusso Role of gemcitabine in metastatic breast cancer patients: a short review Breast 17 2008 220 226 (Pubitemid 351729153)
22. M. Sponziello, A. Scipioni, C. Durante, A. Verrienti, M. Maranghi, L. Giacomelli, E. Ferretti, M. Celano, S. Filetti, and D. Russo Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines J. Endocrinol. Invest. 33 2010 2 6
23. P.G. Tardi, R.C. Gallagher, S. Johnstone, N. Harasym, M. Webb, M.B. Bally, and L.D. Mayer Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo Biochim. Biophys. Acta 1768 2007 678 687 (Pubitemid 46275599)
24. C. Theodossiou, J.A. Cook, J. Fisher, D. Teague, J.E. Liebmann, A. Russo, and J.B. Mitchell Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines Int. J. Oncol. 12 1998 825 832 (Pubitemid 28133574)
25. S. Tomao, A. Romiti, B. Massidda, M.T. Ionta, A. Farris, A. Zullo, A. Brescia, L. Santuari, and L. Frati A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer Anticancer Res. 22 2002 2361 2364 (Pubitemid 34857066)
26. M. Vono, D. Cosco, C. Celia, D. Paolino, M. Celano, D. Russo, and M. Fresta In vitro evaluation of the activity of gemcitabine-loaded pegylated unilamellar liposomes against papillary thyroid cancer cells Open Drug Deliv. J. 4 2010 55 62
27. X. Yan, G.L. Scherphof, and J.A. Kamps Liposome opsonization J. Liposome Res. 15 2005 109 139 (Pubitemid 40976309)
28. A. Zheng, A. Kallio, and P. Härkönen Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen Endocrinology 148 2007 2764 2777 (Pubitemid 46984781)